Cargando…
Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency fol...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046891/ https://www.ncbi.nlm.nih.gov/pubmed/36975469 http://dx.doi.org/10.3390/curroncol30030256 |
_version_ | 1785013785582370816 |
---|---|
author | Richter, Karolina Stefura, Tomasz Kłos, Nikola Tempski, Jonasz Kołodziej-Rzepa, Marta Kisielewski, Michał Wojewoda, Tomasz Wysocki, Wojciech M. |
author_facet | Richter, Karolina Stefura, Tomasz Kłos, Nikola Tempski, Jonasz Kołodziej-Rzepa, Marta Kisielewski, Michał Wojewoda, Tomasz Wysocki, Wojciech M. |
author_sort | Richter, Karolina |
collection | PubMed |
description | To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency follow-up strategies for early-stage melanoma patients. The value of our study consists in the precise analysis of a large collection of articles and the selection of the most valuable works in relation to the topic according to rigorous criteria, which allowed for a thorough study of the topic. The search strategy was implemented using multiple databases. The inclusion criteria were randomized clinical trial or cohort studies that compared the outcomes of a conventional follow-up schedule versus a reduced-frequency follow-up schedule for patients diagnosed with melanoma. In this study, authors analyzed recurrence and 3-year survival. Meta-analysis of outcomes presented by Deckers et al. and Moncrieff et. al. did not reveal a significant difference favoring one of the groups (OR 1.14; 95%CI: 0.65–2.00; p = 0.64). The meta-analysis of 3-year overall survival included two studies. The statistical analysis showed no significant difference in favor of the conventional follow-up group. (OR 1.10; 95%CI: 0.57–2.11; p = 0.79). Our meta-analysis shows that there is no advantage in a conventional follow-up regimen over a reduced-frequency regimen in early-stage melanoma patients. |
format | Online Article Text |
id | pubmed-10046891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100468912023-03-29 Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis Richter, Karolina Stefura, Tomasz Kłos, Nikola Tempski, Jonasz Kołodziej-Rzepa, Marta Kisielewski, Michał Wojewoda, Tomasz Wysocki, Wojciech M. Curr Oncol Communication To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency follow-up strategies for early-stage melanoma patients. The value of our study consists in the precise analysis of a large collection of articles and the selection of the most valuable works in relation to the topic according to rigorous criteria, which allowed for a thorough study of the topic. The search strategy was implemented using multiple databases. The inclusion criteria were randomized clinical trial or cohort studies that compared the outcomes of a conventional follow-up schedule versus a reduced-frequency follow-up schedule for patients diagnosed with melanoma. In this study, authors analyzed recurrence and 3-year survival. Meta-analysis of outcomes presented by Deckers et al. and Moncrieff et. al. did not reveal a significant difference favoring one of the groups (OR 1.14; 95%CI: 0.65–2.00; p = 0.64). The meta-analysis of 3-year overall survival included two studies. The statistical analysis showed no significant difference in favor of the conventional follow-up group. (OR 1.10; 95%CI: 0.57–2.11; p = 0.79). Our meta-analysis shows that there is no advantage in a conventional follow-up regimen over a reduced-frequency regimen in early-stage melanoma patients. MDPI 2023-03-14 /pmc/articles/PMC10046891/ /pubmed/36975469 http://dx.doi.org/10.3390/curroncol30030256 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Richter, Karolina Stefura, Tomasz Kłos, Nikola Tempski, Jonasz Kołodziej-Rzepa, Marta Kisielewski, Michał Wojewoda, Tomasz Wysocki, Wojciech M. Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title | Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title_full | Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title_fullStr | Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title_full_unstemmed | Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title_short | Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis |
title_sort | conventional versus reduced-frequency follow-up in early-stage melanoma survivors: a systematic review with meta-analysis |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046891/ https://www.ncbi.nlm.nih.gov/pubmed/36975469 http://dx.doi.org/10.3390/curroncol30030256 |
work_keys_str_mv | AT richterkarolina conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT stefuratomasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT kłosnikola conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT tempskijonasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT kołodziejrzepamarta conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT kisielewskimichał conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT wojewodatomasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis AT wysockiwojciechm conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis |